Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
Immunotherapy Advances · 01.01.2021 · 1 (1)
DOI: 10.1093/immadv/ltab015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 02.07.2021. Verfasst von Sifan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Imperial College London, London, UK. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Imperial Biomedical Research Centre, NIHR Imperial Clinical Research Facility, National Health Service.
Abstract (Originalsprache)
Immunopathogenesis involving T lymphocytes, which play a key role in defence against viral infection, could contribute to the spectrum of COVID-19 disease and provide an avenue for treatment. To address this question, a review of clinical observational studies and autopsy data in English and Chinese languages was conducted with a search of registered clinical trials. Peripheral lymphopenia affecting CD4 and CD8 T cells was a striking feature of severe COVID-19 compared with non-severe disease. Autopsy data demonstrated infiltration of T cells into organs, particularly the lung. Seventy-four clinical trials are on-going that could target T cell-related pathogenesis, particularly IL-6 pathways. SARS-CoV-2 infection interrupts T cell circulation in patients with severe COVID-19. This could be due to redistribution of T cells into infected organs, activation induced exhaustion, apoptosis, or pyroptosis. Measuring T cell dynamics during COVID-19 will inform clinical risk-stratification of hospitalised patients and could identify those who would benefit most from treatments that target T cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Disease, Imperial College London, London, UK.
- Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
ORCID-Profile: Katrina M Pollock
Förderung
- NIHR Imperial Biomedical Research Centre
- NIHR Imperial Clinical Research Facility
- National Health Service
- National Institute for Health Research
- Department of Health and Social Care
Zitieren
APA
Zhang, S., Asquith, B., Szydlo, R., Tregoning, J. S., & Pollock, K. M. (2021). Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact. Immunotherapy Advances, 1(1). https://doi.org/10.1093/immadv/ltab015
Vancouver
Zhang S, Asquith B, Szydlo R, Tregoning JS, Pollock KM. Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact. Immunotherapy Advances. 2021;1(1). doi:10.1093/immadv/ltab015
BibTeX
@article{Zhang2021,
author = {Zhang, Sifan and Asquith, Becca and Szydlo, Richard and Tregoning, John S and Pollock, Katrina M},
title = {Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact},
journal = {Immunotherapy Advances},
year = {2021},
volume = {1},
number = {1},
doi = {10.1093/immadv/ltab015}
}
EUVIMED